Correlation Between Telix Pharmaceuticals and Althea Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Althea Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Althea Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Althea Group Holdings, you can compare the effects of market volatilities on Telix Pharmaceuticals and Althea Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Althea Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Althea Group.

Diversification Opportunities for Telix Pharmaceuticals and Althea Group

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Telix and Althea is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Althea Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Althea Group Holdings and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Althea Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Althea Group Holdings has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Althea Group go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Althea Group

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 0.57 times more return on investment than Althea Group. However, Telix Pharmaceuticals is 1.76 times less risky than Althea Group. It trades about 0.12 of its potential returns per unit of risk. Althea Group Holdings is currently generating about 0.01 per unit of risk. If you would invest  619.00  in Telix Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of  2,262  from holding Telix Pharmaceuticals or generate 365.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Althea Group Holdings

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Althea Group Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Althea Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Telix Pharmaceuticals and Althea Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Althea Group

The main advantage of trading using opposite Telix Pharmaceuticals and Althea Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Althea Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Althea Group will offset losses from the drop in Althea Group's long position.
The idea behind Telix Pharmaceuticals and Althea Group Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets